About Megakaryo
Megakaryo is a company based in Kyoto (Japan) founded in 2011.. Megakaryo has raised $33.13 million across 3 funding rounds from investors including Japan Asia Investment, INCJ and SMBC Venture Capital. Megakaryo operates in a competitive market with competitors including Freeline, Blue Rock Therapeutics, Disc Medicine, Aspen Neuroscience and Keros Therapeutics, among others.
- Headquarter Kyoto, Japan
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$33.13 M (USD)
in 3 rounds
-
Latest Funding Round
$21.19 M (USD), Series B
Mar 23, 2015
-
Investors
Japan Asia Investment
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Megakaryo
Megakaryo has successfully raised a total of $33.13M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $21.19 million completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $21.2M
-
First Round
First Round
(01 Sep 2011)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2015 | Amount | Series B - Megakaryo | Valuation | INCJ , SMBC Venture Capital |
|
| Aug, 2013 | Amount | Series A - Megakaryo | Valuation | INCJ , SMBC Venture Capital |
|
| Sep, 2011 | Amount | Seed - Megakaryo | Valuation | JST |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Megakaryo
Megakaryo has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Japan Asia Investment, INCJ and SMBC Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment activities in various industries are conducted by INCJ.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Megakaryo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Megakaryo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Megakaryo Comparisons
Competitors of Megakaryo
Megakaryo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Freeline, Blue Rock Therapeutics, Disc Medicine, Aspen Neuroscience and Keros Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
|
| domain | founded_year | HQ Location |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of hematologic diseases
|
|
| domain | founded_year | HQ Location |
Provider of genomic-based personalised pluripotent stem cell therapy
|
|
| domain | founded_year | HQ Location |
Small molecules are developed to treat hematologic and musculoskeletal disorders.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for chronic diseases by targeting mast cells and stem cells
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Megakaryo
When was Megakaryo founded?
Megakaryo was founded in 2011.
Where is Megakaryo located?
Megakaryo is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Is Megakaryo a funded company?
Megakaryo is a funded company, having raised a total of $33.13M across 3 funding rounds to date. The company's 1st funding round was a Seed of $130.1K, raised on Sep 01, 2011.
What does Megakaryo do?
Megakaryon develops and commercializes the technology to produce and store platelets and red blood cells from iPS cell lines. The cell lines are used to develop blood products that can be supplied in a stable manner. The products can be used for blood transfusion and lower the dependence on blood donations. The company claims that it has obtained a patent for mass production of platelets from iPS cells.
Who are the top competitors of Megakaryo?
Megakaryo's top competitors include Keros Therapeutics, Blue Rock Therapeutics and Disc Medicine.
Who are Megakaryo's investors?
Megakaryo has 10 investors. Key investors include Japan Asia Investment, INCJ, SMBC Venture Capital, Mizuho Capital, and Mitsubishi UFJ Capital.